These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6135648

  • 1. Clostridium difficile and inflammatory bowel disease.
    Greenfield C, Aguilar Ramirez JR, Pounder RE, Williams T, Danvers M, Marper SR, Noone P.
    Gut; 1983 Aug; 24(8):713-7. PubMed ID: 6135648
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clostridium difficile, sulphasalazine, and ulcerative colitis.
    Burke DA, Axon AT.
    Postgrad Med J; 1987 Nov; 63(745):955-7. PubMed ID: 2897683
    [Abstract] [Full Text] [Related]

  • 5. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R, Walker JG, West B, Hill MJ.
    Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Lack of relationship between Clostridium difficile toxin and inflammatory bowel disease in children.
    Hyams JS, McLaughlin JC.
    J Clin Gastroenterol; 1985 Oct; 7(5):387-90. PubMed ID: 4067226
    [Abstract] [Full Text] [Related]

  • 13. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
    Pearce CB, Duncan HD, Timmis L, Green JR.
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
    [Abstract] [Full Text] [Related]

  • 14. Serum bacterial toxins are related to the progression of inflammatory bowel disease.
    Qiu H, Sun X, Sun M, He C, Li Z, Liu Z.
    Scand J Gastroenterol; 2014 Jul; 49(7):826-33. PubMed ID: 24853095
    [Abstract] [Full Text] [Related]

  • 15. Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients.
    Hojsak I, Ferenc T, Bojanić K, Mišak Z, Močić Pavić A, Lukić-Grlić A, Kolaček S.
    Digestion; 2012 Jul; 86(1):6-11. PubMed ID: 22688504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clostridium difficile and its cytotoxin in the stools of young hospitalized children. Influence of antibiotic treatment].
    Collignon A, Cotte-Laffitte J, Quero AM, Torlotin JC.
    Pathol Biol (Paris); 1986 Nov; 34(9):977-82. PubMed ID: 3543815
    [Abstract] [Full Text] [Related]

  • 18. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
    De Barbeyrac B, Guinet R, Quentin C, Cantet P, Bebear C.
    Ann Biol Clin (Paris); 1989 Nov; 47(2):67-70. PubMed ID: 2660635
    [Abstract] [Full Text] [Related]

  • 19. Clostridium difficile and its cytotoxin in infants admitted to hospital with infectious gastroenteritis.
    Ellis ME, Mandal BK, Dunbar EM, Bundell KR.
    Br Med J (Clin Res Ed); 1984 Feb 18; 288(6416):524-6. PubMed ID: 6421363
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases.
    Ricciardi R, Ogilvie JW, Roberts PL, Marcello PW, Concannon TW, Baxter NN.
    Dis Colon Rectum; 2009 Jan 18; 52(1):40-5. PubMed ID: 19273954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.